Search Results 571-580 of 18233 for Immunode

1. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

   Has a diagnosis of immunodeficiency or is receiving systemic steroid therapy ... Patients known to be human immunodeficiency virus (HIV) positive are ...

2. Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer - Mayo Clinic

   Has a diagnosis of immunodeficiency or is receiving any systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior to Day 1 of ...

3. A Study of Pembrolizumab Alone as Therapy for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   Diagnosis of immunodeficiency or receiving systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior to the first dose of ...

4. A Study to Evaluate the Safety and Effectiveness of Intratumoral and Intravenous Injection of Vesicular Stomatitis Virus Expressing Human Interferon Beta, and Tyrosinase Related Protein 1 (VSV-IFNb-TYRP1) in Patients with Metastatic Ocular Melanoma and Previously Treated Patients with Unresectable Stage III/IV Cutaneous Melanoma - Mayo Clinic

   Known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies). Known acute or chronic hepatitis B or hepatitis C infection (requires negative ...

5. A Study to Investigate the Effectiveness of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis - Mayo Clinic

   ... immunodeficiency virus, infection requiring hospitalization or intravenous antimicrobial therapy, or opportunistic infection within 6 months prior to ...

6. Publications - Kimiyo M. Raymond, M.D. - Mayo Clinic

   A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening. J Mol Diagn. 2017 Sep; 19(5):755-765. View PubMed; Tortorelli S, Turgeon CT ...

7. A Study to Evaluate the Effectiveness and Safety of rAd-IFN Administered With Celecoxib and Gemcitabine in Patients With Malignant Pleural Mesothelioma - Mayo Clinic

   Has a congenital or acquired immunodeficiency, including patients with known history of infection with human immunodeficiency virus. Participating Mayo ...

8. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

   * Active primary immunodeficiency/active infectious disease(s). * Active tuberculosis infection. Participating Mayo Clinic locations. Study statuses change ...

9. IL-33 Production by Nasal Epithelial Cells - Mayo Clinic

   We will also exclude volunteers who have been diagnosed with an immunodeficiency disease or cystic fibrosis. Participating Mayo Clinic locations. Study ...

10. A Study Assessing HMB-002 In Participants With Von Willebrand Disease - Mayo Clinic

    Has a positive test for Hepatitis B surface antigen (HbsAg), Hepatitis C antibody (HCV Ab), or human immunodeficiency virus antibody (HIV Ab) at Screening ...